NCT05901298 Development of 'My Breastfeeding Guide' Mobile Nursing Application
| NCT ID | NCT05901298 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eastern Mediterranean University |
| Condition | Self Efficacy |
| Study Type | INTERVENTIONAL |
| Enrollment | 88 participants |
| Start Date | 2023-12-15 |
| Primary Completion | 2024-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 88 participants in total. It began in 2023-12-15 with a primary completion date of 2024-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research was planned to develop the "My Breastfeeding Guide" mobile nursing application, which was developed based on Dennis' Breastfeeding Self-Efficacy Theory and Pender's Health Promotion Model, and to determine its effect on the postpartum breastfeeding process, breastfeeding self-efficacy, infant feeding and attachment. The research is in randomized controlled experimental and longitudinal (prospective) design. The research will be carried out with pregnant women who applied to Famagusta State Hospital Obstetrics and Gynecology Polyclinic and a pregnant polyclinic of a private hospital in Famagusta. Pregnant women who applied to Famagusta State Hospital Gynecology and Obstetrics Polyclinic and private hospital's pregnancy polyclinic and met the inclusion criteria of the study will constitute the population of the research. The research will be designed in two groups as the mobile nursing practice group (intervention) and standard care group (control) developed based on Dennis's Breastfeeding Self-Efficacy Theory and Pender's Health Promotion Model. By calculating the sample size in the research, 44 people in the intervention group and 44 people in the control group will reach a total of 88 people. Pregnant Identification Form, Maternal Information Form, Breastfeeding Self-Efficacy Short Form Scale (Postnatal Form), Antenatal Self-Efficacy Short Form Scale, Infant Nutrition Attitude Scale, Breastfeeding Rating Scale, Maternal Attachment Scale and Breastfeeding Self-assessment Form will be used to collect data. Statistical analyzes of the data obtained from the research will be made using the Statistical Package for the Social Science (SPSS) 20.0 package program. While evaluating the research data, frequency, percentage, mean, standard deviation, median, variance analysis from descriptive statistical methods will be used. For homogeneity test between intervention and control groups, the Chi-square test for categorical variables, Mann Whitney test for numerical variables, and sociodemographic variables (age, education status, employment status of himself and his spouse, income level, etc.) and whether the groups are similar in terms of some characteristics. U test will be used. The conformity of the scale scores to the normal distribution will be evaluated with the Shapiro-Wilk test. The results will be evaluated at the 95% confidence level, and the significance at the p\<0.05 level.
Eligibility Criteria
Inclusion Criteria: * Women aged 18 and over, * Women who are in the last trimester of pregnancy (32nd gestational week and above), * Women with singleton pregnancy, * Women who do not have any health problems that may prevent breastfeeding, * Women with smartphones with Android and iOS operating systems, * Women who can access the Internet, * There will be women who do not have literacy problems, mental disabilities and communication problems. Exclusion Criteria: * Women under 18 years of age, * Women who are under the last trimester of pregnancy (32nd week of pregnancy), * Women who do not speak Turkish, * Women who own a smartphone with an operating system other than Android and iOS.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05901298 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Self Efficacy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05901298 currently recruiting?
Yes, NCT05901298 is actively recruiting participants. Contact the research team at emine.temizkan@emu.edu.tr for enrollment information.
Where is the NCT05901298 trial being conducted?
This trial is being conducted at Famagusta, Cyprus.
Who is sponsoring the NCT05901298 clinical trial?
NCT05901298 is sponsored by Eastern Mediterranean University. The trial plans to enroll 88 participants.